Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation

PURPOSE: Triple therapy (TT; inhaled corticosteroid, long-acting muscarinic antagonist, and long-acting β(2)-agonist) is recommended for patients with chronic obstructive pulmonary disease (COPD) at risk of exacerbation, although the optimum timing of TT initiation remains unclear. This study evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Mannino, David, Bogart, Michael, Germain, Guillaume, Huang, Shirley P, Ismaila, Afisi S, Laliberté, François, Jung, Young, MacKnight, Sean D, Stiegler, Marjorie A, Duh, Mei Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906822/
https://www.ncbi.nlm.nih.gov/pubmed/35281476
http://dx.doi.org/10.2147/COPD.S337668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906822/
https://www.ncbi.nlm.nih.gov/pubmed/35281476
http://dx.doi.org/10.2147/COPD.S337668

Ejemplares similares